Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Factor Xa inhibitors from Zeneca for use as anticoagulants/antithrombotics

Oct. 27, 1997

Patents issued to Corvas for serine protease inhibitors

Oct. 22, 1997

Gensia receives FDA approval for desmopressin acetate injection

Oct. 21, 1997

Two large trials support use of alteplase accelerated infusion for acute MI

Oct. 20, 1997

Staphylokinase vs. alteplase for thrombolysis in rabbit stroke model

Oct. 16, 1997

Hirudin more effective than heparin in heart attack patients

Oct. 15, 1997

New antithrombotics/anticoagulants synthesized at Zeneca

Oct. 14, 1997

KBT-3022: pharmacokinetics and pharmacological effects in guinea pigs

Oct. 13, 1997

Merck's new fibrinogen receptor antagonists

Oct. 9, 1997

Mitsui Toatsu's antiplatelet agent slated to enter clinical testing

Oct. 6, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...